Search

Search Constraints

You searched for: Author/Creator Oza, Amit M.

Search Results

1. A Long-Term Extension Study of Bevacizumab in Patients With Solid Tumors. (4th October 2021)

2. A Long‐Term Extension Study of Bevacizumab in Patients With Solid Tumors. (4th October 2021)

4. Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study. Issue 11 (November 2021)

5. Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study. Issue 11 (November 2021)

6. Cancer patients' experiences with immune checkpoint modulators: A qualitative study. (2nd March 2020)

8. Development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT‐ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs. Issue 7 (8th January 2020)

9. Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer. Issue 5 (1st June 2014)